default author photo

Melissa Johnson

Sarah Cannon Research Institute

United Kingdom

SCHOLARLY PAPERS

2

DOWNLOADS

106

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Tiragolumab Plus Atezolizumab Versus Placebo Plus Atezolizumab in Patients with Previously Untreated PD-L1-High, Locally Advanced Unresectable or Metastatic NSCLC (SKYSCRAPER-01): A Phase 3, Randomised, Double-Blind, Placebo-Controlled Study

Number of pages: 36 Posted: 19 Sep 2025
Centre Hospitalier Universitaire Vaudois (CHUV), Yale University, National Cancer Center Hospital, University Hospital 12 de Octubre, Sarah Cannon Research Institute, Peter MacCallum Cancer Centre, Istanbul Medeniyet University, Hacettepe University, Dniprovsky State Medical University, Seoul National University - Department of Internal Medicine, Hospital Vall d’Hebron, Istituto Nazionale Tumori - IRCCS Fondazione G. Pascale, E.J. Zeyland Wielkopolska Center of Pulmonology and Thoracic Surgery, Matrahaza University, National Cancer Center Hospital East, German Centre for Lung Research - Lungen Clinic Grosshansdorf, Genentech, Inc. - San Francisco, Genentech, Inc. - San Francisco, Genentech, Inc. - San Francisco, Genentech, Inc. - San Francisco, Genentech, Inc. - San Francisco, Genentech, Inc. - San Francisco, Genentech, Inc. - San Francisco, Genentech, Inc. - San Francisco and Yonsei University - Yonsei Cancer Center
Downloads 82 (790,029)

Abstract:

Loading...

Non-small cell lung cancer, NSCLC, immune checkpoint inhibitors, anti-TIGIT monoclonal antibody, PD-L1 inhibitor, atezolizumab, tiragolumab, cancer immunotherapy

2.

The TIGOS Trial: A Randomized, Double-Blind, Phase III Trial of Atigotatug and Nivolumab Fixed-Dose Combination With Chemotherapy Versus Atezolizumab With Chemotherapy as First-Line Therapy in Patients With Extensive-Stage Small Cell Lung Cancer

Number of pages: 30 Posted: 24 Nov 2025
Duke University - Duke Cancer Institute, University Hospital 12 de Octubre, Queensland University of Technology, Sarah Cannon Research Institute, German Centre for Lung Research - Lungen Clinic Grosshansdorf, PSL Research University - Institut Curie, Kindai University, Tongji University - Department of Medical Oncology, Bristol Myers Squibb, Bristol Myers Squibb and Bristol Myers Squibb
Downloads 24 (1,399,036)

Abstract:

Loading...

Nivolumab, atigotatug, extensive-stage small cell lung cancer, innate immune inducer, Fuc-GM1